TURBOCAPTURE
LIVE

Serial Number

78756036

Owner

QIAGEN GMBH

Attorney

Victoria Friedman

First Use Date

Jul 31, 2005

Filing Date

Nov 17, 2005

Add to watchlist:

No watchlists yet
View on USPTO

TURBOCAPTURE Trademark

Serial Number: 78756036 • Registration: 3525773

TURBOCAPTURE is a trademark filed by QIAGEN GMBH on November 17, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

November 17, 2005

Registration Date

October 28, 2008

First Use Anywhere

July 31, 2005

First Use in Commerce

July 31, 2005

Published for Opposition

April 8, 2008

Goods & Services

Scientific [ apparatus, instruments and ] equipment, namely, [ strips, ] plates, [ holders for plates, ] in particular for research and examination purposes; [ and ] laboratory equipment, [ measuring apparatus and instruments for medical or veterinary medical diagnostic purposes, ] in particular for the preparation of samples, the [ modification, ] manipulation of cells and for the [ marking, ] separation, isolation, purification, [ reproduction ] and/or analysis of biopolymers, in particular nucleic acids [, proteins, macromolecules and biologically active substances ]

[ Products for medical and veterinary medical purposes, in particular diagnostic preparation, in particular for the preparation of samples, the modification and manipulation of cells and for the marking, separation, isolation, purification and reproduction and the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, in particular reagents and solvents for medical and veterinary use for the preparation of samples, the modification and the manipulation of cells as well as for performing marking, separation, isolation, purification, reproduction and analysis methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits comprising products for medical and veterinary medical diagnostic purposes composed of solutions for protein processing, inhibitor solutions, buffers, wash compositions, binding compositions, random hexamers, primers, reagents, solvents, strips and plates, in particular for the preparation of samples, the modification and manipulation of cells and for marking,separation, isolation, purification, reproduction and analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material ]

[ Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, solutions for protein processing, inhibitor solutions, buffers, wash compositions, binding compositions, random hexamers, primers, reagents, and solvents for the preparation of samples, the modification and manipulation of cells as well as for the marking, separation, isolation, purification, reproduction and the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules, and biologically active substances, in particular nucleic acids from biological and biochemical sample material; diagnostic preparations, except for medical and veterinary medical purposes; reagents and solvents, not for medical or veterinary purposes, and in particular for the preparation of samples, the modification and manipulation of cells as well as for performing marking, separation, isolation, purification, reproduction and/or analysis methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; ] kits comprising chemical products, namely, [solutions for protein processing, inhibitor solutions, ] buffers, wash compositions, binding compositions, [ random hexamers, ] primers, reagents, and solvents for the preparation of samples, the [ modification and ] manipulation of cells as well as for the [ marking, ] separation, isolation, purification, [ reproduction and ] the analysis of biopolymers, in particular nucleic acids, [ proteins, macromolecules, and biologically active substances, ] in particular nucleic acids from biological [ and biochemical ] sample material, other than for medical or veterinary use

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Oct 16, 2018 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 16, 2018 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 16, 2018 89AG
TEAS SECTION 8 & 9 RECEIVED
Oct 8, 2018 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 28, 2017 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 31, 2014 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 31, 2014 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 31, 2014 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 21, 2014 E815
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2008 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 24, 2008 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 23, 2008 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 4, 2008 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 4, 2008 AITU
USE AMENDMENT FILED
Aug 29, 2008 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 29, 2008 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2008 NOAM
PUBLISHED FOR OPPOSITION
Apr 8, 2008 PUBO
NOTICE OF PUBLICATION
Mar 19, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 29, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 29, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 29, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 29, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 29, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 29, 2008 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 29, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 19, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 6, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2008 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jan 25, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2008 CRFA
ASSIGNED TO LIE
Jan 24, 2008 ALIE
PAPER RECEIVED
Dec 12, 2007 MAIL
UNDELIVERABLE MAIL - COURTESY COPY MAILED
Jul 18, 2007 UNDC
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 13, 2007 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 13, 2007 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 13, 2007 CNSI
LETTER OF SUSPENSION E-MAILED
Jan 12, 2007 GNSL
SUSPENSION LETTER WRITTEN
Jan 12, 2007 CNSL
AMENDMENT FROM APPLICANT ENTERED
Dec 27, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2006 CRFA
PAPER RECEIVED
Nov 24, 2006 MAIL
NON-FINAL ACTION E-MAILED
May 24, 2006 GNRT
NON-FINAL ACTION WRITTEN
May 24, 2006 CNRT
ASSIGNED TO EXAMINER
May 16, 2006 DOCK
NEW APPLICATION ENTERED
Nov 22, 2005 NWAP